Pharmaceuticals, Biotechnology and Life Sciences
Third Approval for KEYTRUDA in First-Line NSCLC in China in Less Than One Year KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK),…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…
LONDON–(BUSINESS WIRE)–#EntericFever–Prokarium, a private biotechnology company developing vaccines against infectious diseases and immunotherapy for solid tumors, has received Clinical Trial…
For a fifth consecutive year, Iron Deficiency Day aims to inform about the impact and symptoms of iron deficiency Iron…
Achieved both primary endpoints of clinical remission at weeks 26 and 52 with statistical superiority of avacopan over standard of…
Data to be presented at the 2019 American Epilepsy Society Meeting CVL-865 is an investigational therapy in development for the…
– Conference Call and Webcast Today at 4:30 p.m. EST PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the research, development and commercialization of novel…
PASADENA, Calif.–(BUSINESS WIRE)–Deep 6 AI, the leading provider of clinical trials acceleration software, announced today that it has raised $17M…
TAKOMA PARK, Md.–(BUSINESS WIRE)–#510K–US Medical Innovations, LLC (USMI), a Biomedical and Life Science subsidiary of US Patent Innovations, LLC (USPI)…